» Articles » PMID: 6319055

SLE Like Syndrome and Functional Deficiency of C1q in Members of a Large Family

Overview
Date 1984 Jan 1
PMID 6319055
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Two sisters and a brother from one family are described whose sera were deficient in haemolytic complement function. This defect was restored by addition of purified C1q. In their sera, C1q like material was found, whereas C1r and C1s were normal or increased in concentration, as were the other complement components tested. All three had suffered from glomerulonephritis during childhood. A renal biopsy in the brother recently disclosed a membranous glomerulopathy stage 1; otherwise, he is apparently healthy. In both sisters, a systemic lupus erythematosus like disease became manifest at the age of 20 and 23, respectively, resulting in the death of one of them. In the serum of these three family members, the C1q like material was antigenically deficient compared with normal C1q and had, on sucrose gradient analysis, a molecular weight of approximately 65,000 daltons. It did not bind to C1r and C1s. Binding of the dysfunctional C1q to aggregated human gammaglobulin could be demonstrated. On double immunodiffusion analysis, the abnormal C1q was identical with reduced and alkylated C1q. The possible structure of the abnormal C1q molecule is discussed.

Citing Articles

Drug-resistant epilepsy associated with peripheral complement decreases and sex-specific cytokine imbalances: a pilot study.

Pinzon-Hoyos N, Li Y, McGee M, Poolos N, Marchi N, Brewster A Sci Rep. 2025; 15(1):5096.

PMID: 39934240 PMC: 11814292. DOI: 10.1038/s41598-025-88654-5.


Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus.

Charras A, Hiraki L, Lewandowski L, Hedrich C Curr Opin Rheumatol. 2024; 37(2):149-163.

PMID: 39660463 PMC: 11789615. DOI: 10.1097/BOR.0000000000001072.


Sex-Specific Complement and Cytokine Imbalances in Drug-Resistant Epilepsy: Biomarkers of Immune Vulnerability.

Pinzon-Hoyos N, Li Y, McGee M, Poolos N, Marchi N, Brewster A bioRxiv. 2024; .

PMID: 39345496 PMC: 11429787. DOI: 10.1101/2024.09.16.612934.


The yin and the yang of early classical pathway complement disorders.

Sullivan K Clin Exp Immunol. 2022; 209(2):151-160.

PMID: 35648651 PMC: 9390844. DOI: 10.1093/cei/uxac056.


Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Zhang S, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova J Curr Opin Immunol. 2019; 59:88-100.

PMID: 31121434 PMC: 6774828. DOI: 10.1016/j.coi.2019.03.008.


References
1.
Heusser C, BOESMAN M, Knobel H, JACOT-GUILLARMOD H, ISLIKER H . The effect of reduction and reoxidation on the biological activities and structure of human Clq (first component of complement). Immunochemistry. 1975; 12(3):213-9. DOI: 10.1016/0019-2791(75)90234-7. View

2.
Rosen F, Pensky J, DONALDSON V, CHARACHE P . HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS. Science. 1965; 148(3672):957-8. DOI: 10.1126/science.148.3672.957. View

3.
Schur P . Complement testing in the diagnosis of immune and autoimmune diseases. Am J Clin Pathol. 1977; 68(5 Suppl):647-59. View

4.
Agnello V . Complement deficiency states. Medicine (Baltimore). 1978; 57(1):1-23. DOI: 10.1097/00005792-197801000-00001. View

5.
Porter R, Reid K . The biochemistry of complement. Nature. 1978; 275(5682):699-704. DOI: 10.1038/275699a0. View